Firms and Federal Labs Flock to FDA Seeking Emergency Use Authorization for Ebola MDx Assays | GenomeWeb

NEW YORK (GenomeWeb) ― At least five companies have indicated they will pursue or are considering pursuing Emergency Use Authorization from the US Food and Drug Administration to make nucleic acid tests for Ebola available, while three RT-PCR assays have already been granted EUA since an emergency was declared in early August.

The three real-time RT-PCR tests that have already been granted EUA ― one from the US Department of Defense, and two from the US Centers of Disease Control ― can now be legally used to diagnose patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.